CRISPR Therapeutics (CRSP) PT Lowered to $120 at SMBC Nikko Securities
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $54.28 --0%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
SMBC Nikko Securities analyst David Dai lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $120.00 (from $150.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- Zensho Holdings (7550:JP) PT Raised to JPY13,300 at Nomura/Instinet
- Sansan Inc (4443:JP) PT Raised to JPY2,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
